PKE Stock Analysis: Park Aerospace | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 758m USD | 12M Return: 140.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.8M
EPS Trend: 0.6%
Rev. Trend: 90.0%
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Park Aerospace Corp. (NYSE: PKE) is a U.S.-based aerospace company that develops and manufactures advanced composite materials, primarily film adhesives and hot-melt products, along with specialty ablative materials for rocket motors and radome applications. Its materials are used in primary and secondary structures for a broad range of aircraft, including large and regional transport jets, military aircraft, unmanned aerial vehicles, business jets, general aviation, and rotary wing platforms, with the company serving customers across North America, Asia, and Europe. Beyond materials, Park also designs and fabricates composite parts, structures, assemblies, and low-volume tooling for the aerospace industry. The company was incorporated in 1954, is headquartered in Westbury, New York, and was renamed from Park Electrochemical Corp. to Park Aerospace Corp. in July 2019 to better reflect its aerospace focus.
As a small-cap player in the GICS Aerospace & Defense sub-industry, Park operates in a sector characterized by long product qualification cycles and stringent certification requirements, which create high barriers to entry and tend to favor established suppliers. Its business model spans both upstream materials (resins, adhesives, lightning strike protection) and downstream parts and assemblies, giving it exposure to multiple tiers of the aerospace supply chain.
- Boeing 787 and Airbus A350 production rates drive adhesive demand
- Defense and space programs lift ablative radome materials revenue
- Special dividends signal management confidence in cash flow outlook
| Net Income: 11.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 3.52 > 1.0 |
| NWC/Revenue: 140.1% < 20% (prev 130.6%; Δ 9.48% < -1%) |
| CFO/TA 0.08 > 3% & CFO 11.5m > Net Income 11.3m |
| Net Debt (-89.1m) to EBITDA (16.9m): -5.27 < 3 |
| Current Ratio: 18.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (20.4m) vs 12m ago 1.13% < -2% |
| Gross Margin: 30.93% > 18% (prev 28.44%; Δ 2.49% > 0.5%) |
| Asset Turnover: 55.46% > 50% (prev 50.80%; Δ 4.66% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.72 (Total Current Assets 108.7m - Total Current Liabilities 5.96m) / Total Assets 142.2m |
| B: -0.34 (Retained Earnings -48.2m / Total Assets 142.2m) |
| C: 0.11 (EBIT TTM 15.0m / Avg Total Assets 132.2m) |
| D: 10.58 (Book Value of Equity 129.9m / Total Liabilities 12.3m) |
| Altman-Z'' = 15.51 = AAA |
| DSRI: 0.72 (Receivables 11.0m/12.9m, Revenue 73.3m/62.0m) |
| GMI: 0.92 (GM 28.44% / 30.93%) |
| AQI: 1.00 (AQ_t 0.08 / AQ_t-1 0.08) |
| SGI: 1.18 (Revenue 73.3m / 62.0m) |
| TATA: -0.00 (NI 11.3m - CFO 11.5m) / TA 142.2m) |
| Beneish M = -3.20 (Cap -4..+1) = AA |
As of July 10, 2026, the stock is trading at USD 36.37 with a total of 145,379 shares traded. Over the past week, the price has changed by -4.87%, over one month by +6.07%, over three months by +15.40% and over the past year by +140.41%.
Current recommended Stop Loss: 33.30 (which is 8.4% or 1.5 ATR below the current price).
Park Aerospace has no consensus analysts rating.
| Analysts Target Price | 42 | 15.5% |
P/E Trailing = 66.0182
P/E Forward = 17.094
P/S = 10.3419
P/B = 6.0778
P/EG = 1.4854
Revenue TTM = 73.3m USD
EBIT TTM = 15.0m USD
EBITDA TTM = 16.9m USD
Long Term Debt = 273k USD (estimated: total debt 317k - short term 44.0k)
Short Term Debt = 44.0k USD (from shortTermDebt, last quarter)
Debt = 317k USD (from shortLongTermDebtTotal, last quarter) (leases 317k already included)
Net Debt = -89.1m USD (calculated: Debt 317k - CCE 89.4m)
Enterprise Value = 669.0m USD (758.1m + Debt 317k - CCE 89.4m)
Interest Coverage Ratio = unknown (Ebit TTM 15.0m / Interest Expense TTM 0.0)
EV/FCF = 70.71x (Enterprise Value 669.0m / FCF TTM 9.46m)
FCF Yield = 1.41% (FCF TTM 9.46m / Enterprise Value 669.0m)
FCF Margin = 12.91% (FCF TTM 9.46m / Revenue TTM 73.3m)
Net Margin = 15.38% (Net Income TTM 11.3m / Revenue TTM 73.3m)
Gross Margin = 30.93% ((Revenue TTM 73.3m - Cost of Revenue TTM 50.6m) / Revenue TTM)
Gross Margin QoQ = 28.67% (prev 34.06%)
Tobins Q-Ratio = 4.70 (Enterprise Value 669.0m / Total Assets 142.2m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 317k)
Taxrate = 25.07% (3.77m / 15.0m)
NOPAT = 11.3m (EBIT 15.0m * (1 - 25.07%))
Current Ratio = 18.24 (Total Current Assets 108.7m / Total Current Liabilities 5.96m)
Debt / Equity = 0.00 (Debt 317k / totalStockholderEquity, last quarter 129.9m)
Debt / EBITDA = -5.27 (Net Debt -89.1m / EBITDA 16.9m)
Debt / FCF = -9.41 (Net Debt -89.1m / FCF TTM 9.46m)
Total Stockholder Equity = 111.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.53% (Net Income 11.3m / Total Assets 142.2m)
RoE = 10.08% (Net Income TTM 11.3m / Total Stockholder Equity 111.8m)
RoCE = 13.42% (EBIT 15.0m / Capital Employed (Equity 111.8m + L.T.Debt 273k))
RoIC = 8.50% (NOPAT 11.3m / Invested Capital 132.6m)
WACC = 9.10% (E(758.1m)/V(758.4m) * Re(9.10%) + D(317k)/V(758.4m) * Rd(0.0%) * (1-Tc(0.25)))
Discount Rate = 9.10% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -24.44 | Cagr: 0.14%
[DCF] Terminal Value 75.59% ; FCFF base≈7.21m ; Y1≈8.26m ; Y5≈12.2m
[DCF] Fair Price = 12.01 (EV 161.8m - Net Debt -89.1m = Equity 250.8m / Shares 20.9m; r=9.10% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 0.56 | EPS CAGR: 0.12% | SUE: N/A | # QB: 0
Revenue Correlation: 90.00 | Revenue CAGR: 9.73% | SUE: N/A | # QB: 0
EPS current Quarter (2026-05-31): EPS=0.14 | Chg30d=N/A | Revisions=+0% | Analysts=1
EPS next Quarter (2026-08-31): EPS=0.13 | Chg30d=N/A | Revisions=+0% | Analysts=1
EPS current Year (2027-02-28): EPS=0.60 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+7.1% | GrowthRev=+0.0%
EPS next Year (2028-02-29): EPS=0.76 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+26.7% | GrowthRev=+19.9%